Could virtual reality help soothe dizziness better than standard therapy?
NCT ID NCT07703085
First seen Jul 14, 2026 · Last updated Jul 15, 2026 · Updated 1 time
Summary
This study tests whether virtual reality-assisted vestibular rehabilitation can reduce dizziness and improve balance and walking more than conventional vestibular rehabilitation in people with benign paroxysmal positional vertigo (BPPV). Participants, aged 18 to 40 with residual dizziness after canalith repositioning, are randomly assigned to either VR-based or standard rehab sessions over four weeks. Outcomes are measured using validated scales for dizziness, balance, and gait.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- virtual reality-assisted vestibular rehabilitation and conventional vestibular rehabilitation
- What this could lead to
- If VR-assisted rehab proves more effective, it could offer a more engaging and potentially faster way to reduce dizziness and improve balance in people with BPPV.
- What could go wrong
- This is a small, early-stage study with only 32 participants, so results may not apply broadly. VR may cause motion sickness or discomfort in some users.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 32 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2026
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Participants of both genders. * Adults aged 18-40 years. * Clinically diagnosed with posterior canal Benign Paroxysmal Positional Vertigo (BPPV) confirmed by a positive Dix-Hallpike test, with a duration of at least one month since diagnosis. * Individuals who have undergone canalith repositioning maneuvers and demonstrate resolution of positional nystagmus. * Presence of residual dizziness and/or balance impairment persisting after repositioning treatment. * Ability to ambulate independently and safely participate in balance-related exercises. * Willingness to participate in the study and provide written informed consent. Exclusion Criteria: * Central vestibular disorders * Cervical spine instability or severe neck pain * History of recent head trauma (\<3 months) * Neurological disorders affecting balance * Severe visual or cognitive impairment preventing VR use * Patients of Vertebrobasilar insufficiency (VBI)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign proximal positional vertigo (BPPV) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lahore University of Biological and Applied Sciences
Lahore, Punjab Province, Pakistan